GeneDx Holdings Corp. (WGS) — Stock Price, Chart & Analysis
GeneDx Holdings Corp. (WGS) is a Healthcare stock currently trading at $90.8, up 63.84% on the day. It carries a market capitalization of $2.71B. Over the past 52 weeks, WGS has traded between $32.21 and $170.87. GeneDx Holdings Corp. does not currently pay a regular dividend. View the live WGS chart, technical opinion, analyst ratings, fundamentals and latest news below.
GeneDx Holdings Corp. (WGS) key data
| Price | $90.8 |
| Change (today) | +63.84% |
| Previous close | $55.42 |
| Market cap | $2.71B |
| EPS (TTM) | $-3.63 |
| 52-week high | $170.87 |
| 52-week low | $32.21 |
| Beta | 2.01 |
| Avg. volume | 717.7K |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Frequently asked questions about GeneDx Holdings Corp. (WGS)
How much does one share of GeneDx Holdings Corp. cost?
As of the latest update, one share of GeneDx Holdings Corp. (WGS) trades at $90.8 (+63.84% today).
What is GeneDx Holdings Corp.'s market cap?
GeneDx Holdings Corp. has a market capitalization of approximately $2.71B.
What is GeneDx Holdings Corp.'s earnings per share (EPS)?
GeneDx Holdings Corp.'s trailing twelve-month EPS is $-3.63.
Does GeneDx Holdings Corp. pay a dividend?
GeneDx Holdings Corp. does not currently pay a regular dividend.
What is GeneDx Holdings Corp.'s 52-week trading range?
Over the past year, WGS has traded between $32.21 and $170.87.
What is the analyst price target for GeneDx Holdings Corp.?
The mean analyst price target for GeneDx Holdings Corp. is $90.44. This is informational only and not investment advice.
Latest GeneDx Holdings Corp. (WGS) news
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’sNews · Aug 24, 2026
- Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?News · Aug 19, 2026
- GeneDx (WGS) Q2 2026 Earnings Call TranscriptNews · Aug 11, 2026
- GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ...News · Aug 4, 2026
- GeneDx Q2 Earnings Call HighlightsNews · Aug 3, 2026
- GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of ExpectationsNews · Jul 21, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live WGS dashboard…